NantHealth (NH) Reports In-Line Q3 EPS

NantHealth (NASDAQ: NH) reported Q3 Adj. EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $21.8 million versus the consensus estimate of $29.23 million.

For earnings history and earnings-related data on NantHealth (NH) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance